| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7b4beef0c137d9094e6918ee382be22f |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D473-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D473-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D473-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D473-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D473-38
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D473-32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D473-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C43-1786
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C43-1785 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D473-32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D473-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D473-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D473-38
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D473-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D473-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D473-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C43-178 |
| filingDate |
1985-06-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
1986-09-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_efaf37810a83f1af25f98b8d2899397f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3ad95696b3c5553fed1249c59d905c04 |
| publicationDate |
1986-09-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-4612314-A |
| titleOfInvention |
Substituted 9-(1 or 3-monoacyloxy or 1,3-diacyloxy-2-propoxymethyl) purines as antiviral agent |
| abstract |
Compounds useful as antiviral agents are defined by the following formula: <IMAGE> (I) and the pharmaceutically acceptable acid addition salts thereof wherein R1 and R2 are both -C(O)R7 wherein R7 is 1-adamantyl; R3 is amino; (a) R6 is hydrogen or amino and R4 together with R5 is a bond; or (b) R5 together with R6 is a keto group and R4 is hydrogen. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AU-637362-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5079252-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-8803923-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4916225-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4853386-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5334395-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5316775-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0212535-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5284664-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5055296-A |
| priorityDate |
1982-12-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |